Our preliminary analysis showed that the expression of SLC2A5 was upregulated in non-small-cell lung cancer (NSCLC) samples compared to normal lung tissue, but the implication of SLC2A5 upregulation in lung cancer was largely unknown. The gene discussed is SLC2A5; the disease is lung carcinoma.